SNY - Pfizer Agrees To Settle Over 10000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac | Benzinga
Pfizer Inc (NYSE:PFE) has reportedly settled 10,000 lawsuits alleging it concealed the cancer risks associated with its Zantac heartburn medication, marking the largest resolution in the litigation.
The agreements span various state courts across the U.S. but do not entirely mitigate the company’s exposure to Zantac-related claims.
Financial specifics of the settlements have not been disclosed, Bloomberg noted, citing people familiar with the matter.
Despite this significant resolution, ...